SARTORIUS STEDIM BIOTECH earnings per share and revenue

56S1 earnings per share for the last quarter are 1.22 EUR whereas the estimation was 1.04 EUR which accounts for 17.50% surprise. Company revenue for the same period amounts to 884.30 M EUR despite the estimated figure of 735.83 M EUR. Estimated earnings per share for the next quarter are 0.97 EUR, and revenue is expected to reach 716.63 M EUR. Also watch annual changes over time to get a bigger picture of 56S1 earnings per share and revenue dynamics.